A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 276
Last updated 2024-09-19
Summary
This study is a multi-center, observational study aiming at developing a machine learning-based early detection model using prospectively collected liquid biopsy samples from clinically-annotated individuals.
Conditions
Sponsors & Collaborators
-
Shanghai Weihe Medical Laboratory Co., Ltd.
collaborator INDUSTRY -
Fudan University
lead OTHER
Principal Investigators
-
Xian-Jun Yu, M.D., Ph.D. · Fudan University
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-18
- Primary Completion
- 2026-10-31
- Completion
- 2027-03-31
Countries
- China
Study Locations
More Related Trials
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
NCT05556603 ·Status: RECRUITING
-
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
NCT04241367 ·Status: COMPLETED
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
NCT06760234 ·Status: COMPLETED
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED
-
Pancreatic Cancer Initial Detection Via Liquid Biopsy
NCT06283576 ·Status: ENROLLING_BY_INVITATION
-
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT07030348 ·Status: RECRUITING
-
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
NCT05621824 ·Status: NOT_YET_RECRUITING
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
NCT06495749 ·Status: NOT_YET_RECRUITING
-
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
NCT06139042 ·Status: RECRUITING
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 ·Status: UNKNOWN
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer
NCT04293497 ·Status: COMPLETED ·Phase: NA
-
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866 ·Status: RECRUITING
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
NCT06320717 ·Status: RECRUITING
-
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045 ·Status: RECRUITING
-
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
NCT02471170 ·Status: ENROLLING_BY_INVITATION
-
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
NCT04536220 ·Status: RECRUITING
-
sCD8, as a Novel Biomarker for Pancreatic Cancer
NCT05500027 ·Status: RECRUITING
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques
NCT05289895 ·Status: UNKNOWN
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
NCT06411470 ·Status: RECRUITING